Related Experiment Video

Updated: May 13, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Suppression of Toll-like receptor 4 activation by endogenous oxidized phosphatidylcholine, KOdiA-PC by inhibiting LPS

Min Jin Kim1, Na Young Choi, Jung Eun Koo

  • 1College of Pharmacy, The Catholic University of Korea, Bucheon 420-743, Korea.

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|March 12, 2013
PubMed
Abstract

Insights

Oxidized phosphatidylcholine (KOdiA-PC) inhibits Toll-like receptor 4 (TLR4) activation by blocking LPS binding to MD2. This mechanism reduces inflammatory responses and macrophage migration, suggesting a role for oxidized lipids in resolving inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Toll-like receptor 4 (TLR4) activation is crucial in immune responses against pathogens and endogenous danger signals.
  • Dysregulated TLR4 signaling contributes to chronic inflammatory diseases.
  • Oxidized phospholipids, such as 1-palmitoyl-2-(5-keto-6-octenedioyl)-sn-glycero-3-phosphocholine (KOdiA-PC), are endogenous molecules implicated in inflammatory processes.

Purpose of the Study:

  • To investigate the effect of KOdiA-PC on TLR4 activation.
  • To elucidate the underlying regulatory mechanism of KOdiA-PC's action on TLR4 signaling.
  • To determine if KOdiA-PC can modulate inflammatory mediator production and macrophage behavior.

Main Methods:

  • RAW264.7 macrophages were utilized to assess inflammatory responses.
  • Quantitative PCR and ELISA were employed to measure TNF-α, IFN-β, and COX-2 expression.
  • Immunoblot and luciferase reporter assays were used to examine TLR4 signaling pathway activation.
  • In vitro binding assays determined the interaction between LPS, MD2, and KOdiA-PC.
  • Macrophage migration was analyzed using transwell assays.

Main Results:

  • KOdiA-PC effectively prevented the activation of key TLR4 signaling components, including ERK, JNK, p38, NF-κB, and IRF3.
  • Treatment with KOdiA-PC led to a significant decrease in the expression of inflammatory mediators TNF-α, IFN-β, and COX-2.
  • In vitro studies demonstrated that KOdiA-PC disrupts the binding of lipopolysaccharide (LPS) to MD2, a critical co-receptor for TLR4.
  • KOdiA-PC suppressed LPS-induced macrophage migration.

Conclusions:

  • KOdiA-PC modulates TLR4 activation by interfering with ligand-receptor interactions, specifically blocking LPS binding to MD2.
  • These findings suggest that endogenously generated oxidized phospholipids, like KOdiA-PC, can play a role in resolving inflammation.
  • KOdiA-PC terminates TLR activation and reduces macrophage recruitment to inflammatory sites, indicating a potential therapeutic strategy.

More Related Videos

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

Related Concept Videos

Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Inflammation01:38

Inflammation

Overview
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...